Tumor markers such as alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), CA19–9, CA72.4, and CA125 have low sensitivity 34 (<40%), and their specificities are modest for GC patients [4]. This evidence concerns the gene CEACAM5 and neoplasm.